Introduction Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition with impacts on behaviour, cognition, communication, social interaction and family mental health. This paper reports the protocol of a randomised controlled trial (RCT) of a very early intervention, ENACT (ENvironmental enrichment for infants; parenting with Acceptance and Commitment Therapy), for families of infants at risk of ASD.
Methods and analysis We aim to recruit 66 mothers of infants at risk of ASD (ie, infants with a sibling or parent diagnosed with ASD) to this RCT. Families will be randomly assigned to care-as-usual or ENACT. ENACT is a very early intervention, leveraging parent–child interactions to improve early social reciprocity, while supporting parental mental health and the parent–child relationship through Acceptance and Commitment Therapy. Intervention content is delivered online (approximately 8 hours) and supported by more than 7 consultations with a clinician. Parents will perform the social reciprocity intervention with their child (30 min per day). Assessments at four time points (baseline, 3 months, 6 months, and 12 months corrected age) will assess parent–infant interaction, parental mental health, infant development and early ASD markers. Analysis will be by intention to treat using general linear models for RCTs.
Ethics and dissemination This protocol has been approved by the Children’s Health Queensland Hospital and Health Service Human Research Ethics Committee (HREC/19/QCHQ/50131) and the University of Queensland Human Research Ethics Committee (2019000558). If efficacy is demonstrated, the intervention has the potential for wide and accessible dissemination.
Trial registration number Australian New Zealand Clinical Trials Registry (ACTRN12618002046280).
- autism spectrum disorder
- early intervention
- maternal mental health
- parent-infant interaction
- infant development
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
- autism spectrum disorder
- early intervention
- maternal mental health
- parent-infant interaction
- infant development
Strengths and limitations of this study
First randomised controlled trial to test a very early intervention for infants at risk of autism spectrum disorder implemented within the first 6 months of life.
ENACT (ENvironmental enrichment for infants; parenting with Acceptance and Commitment Therapy) combines parent-mediated very early intervention with parental mental health support.
Assessment includes neurodevelopmental assessments, as well as observations of parent–child interaction.
ENACT is designed to be delivered by health professionals with relevant clinical experience in working with parents and in Acceptance and Commitment Therapy, and could, if effective, be widely disseminated at little cost.
Autism spectrum disorder and the broader autism phenotype
Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition defined by difficulties in social communication and interaction, and repetitive, restricted interests and activities.1 2 It evolves from a complex interaction between genes and environment,3 4 and has substantial impact on affected individuals, with 65% having a profound or severe activity limitation, needing help or supervision with communication, self-care and/or mobility.5 Prevalence rates are 0.7% and 1.7%–2.5% in Australia and the United States, respectively.5–7 Diagnosis rests on developmental assessment and behavioural observations, with most children 2 years or older at diagnosis.8
Infant siblings of children with ASD are at an increased risk of ASD themselves, with prevalence estimates of 18%–20% from baby sibling studies.9 10 A further 25% show elevated scores on the Autism Diagnostic Observation Schedule, developmental delays and lower adaptive functioning.11–13 Prospective sibling studies have identified a range of non-specific markers in infants at a high risk of ASD, including motor delays, poor visual reception, language delays, regulatory difficulties and changes in eye gaze at 6–12 months that precede the appearance of autism-specific features in the second year of life.14–18 The diversity of early markers precludes a single developmental pathway to ASD and has been called ‘the first year puzzle’.19–23 Non-specific developmental markers may interact leading to increasingly abnormal trajectories of infant development. Visual, motor and regulatory difficulties may impact on emerging attention and emotional regulation.19 24–26 Differences in visual, motor and regulatory abilities at 6 months of age correspond in timing with changes in whole-brain functional connectivity on MRI studies.27 28 At 6 months of age, functional connectivity on diffusion tensor imaging MRI correctly predicted 9 of 11 infants that went on to be diagnosed with ASD at 24 months of age.29 These findings support the conjecture that the developmental cascade leading to ASD begins early, within the first 6 months of life.28
To date, nine randomised controlled trials (RCTs) have tested parent-mediated early interventions with infants at risk of ASD implemented in the first 24 months, prior to confirmed ASD diagnosis.30–36 Only one of these, an RCT of Intervention within the British Autism Study of Infant Siblings- Video Interaction to Promote Positive Parenting Programme (iBASIS-VIPP), conducted with 54 infants at high familial risk of ASD recruited at 7–10 months of age has demonstrated sustained reduction of ASD-related symptoms, but no change in the diagnostic outcome at 3 years.30 34 37–39 iBASIS-VIPP begins after the infant is 6 months of age and focuses on changing parent behaviour. To date, no RCT has commenced with at-risk infants before the infants reach 6 months of age, before earliest ASD markers and commencement of the cascade.
ASD in the family context
Poor maternal mental health contributes to poorer long-term outcomes for infants, including those at risk of ASD.40 41 Parents of children with ASD are at increased risk for depression and anxiety,42 43 both due to parenting challenges and pre-existing histories.44–46 Parents of infants with ASD are more likely to have an ASD or the broader autism phenotype (BAP).47–50 The BAP may include rigidity, aloofness, social and communication difficulties,50 with increased risk of depressive symptomatology, maladaptive coping and decreased social support.50
Mental health difficulties can contribute to reductions in responsive parenting.51 Responsive parenting—child-directed, contingent, prompt and appropriate to the child’s needs—is associated with better child outcomes.52 53 Responsiveness is a dose-control system for environmental enrichment, enabling the child to obtain the necessary ‘experience expectant development’.54 55 If a child is difficult to read, sends atypical or unclear signals, as in ASD, it is more challenging for parents to cultivate responsive patterns of interaction.56
By 6 months, infants at risk of ASD may be showing an atypical style of interaction, with difficulty engaging in eye contact and joint attention.15 26 53 57 58 Parent behaviour may shift towards intrusive parenting and high-intensity approach behaviours in an attempt to foster engagement and overcome the emerging social limitations of ASD.53 59 The shift to directive parenting may impact further on the infant’s social development.53 60 Importantly, commencing parent-focused intervention prior to 6 months, before the shift towards directive parenting, has not been tested.
To test the efficacy of ENACT (ENvironmental enrichment for infants; parenting with Acceptance and Commitment Therapy) for families of infants at risk of ASD via an RCT comparing ENACT to care-as-usual (CAU). ENACT is a newly developed, very early intervention that targets infants’ social reciprocity through supported parent–infant interactions, while simultaneously supporting parental mental health and the parent–child relationship. ENACT commences prenatally.
We predict that families allocated to ENACT will show better outcomes compared with families allocated to CAU in terms of having the following.
H1: lower scores for ASD symptomatology as assessed on (a) the Autism Observation Schedule in Infants (AOSI)61 62 at 12 months and (b) the greater ease of disengagement and greater reduction in the gap effect (reaction time at overlap minus reaction time at gap) on the gap–overlap task at 12 months in comparison to 6 months.63,64
H2: better scores on measures of parents’ mental health at 3 months, 6 months and 12 months as assessed on the Depression, Anxiety Stress Scale-21 items (DASS-21) and the Acceptance and Action Questionnaire-II (AAQ-II).65 66
H3: improved parent–infant interaction, with greater emotional availability and parental sensitivity, less parental intrusiveness and greater child responsiveness, as assessed on the Emotional Availability Scales (EAS): self-report at 3 months, 6 months and 12 months and observed67 at 6 months.
H4: higher scores on measures of (a) infants’ cognitive development, assessed using the Mullen Scales of Early Learning (MSEL) Early Learning Composite (ELC) at 6 months and 12 months (a composite of the subdomains of visual reception (VR), fine motor (FM), receptive language (RL) and expressive language (EL)),68 and (b) infants’ adaptive skills, assessed using the Vineland Adaptive Behavior Scales, Third Edition (VABS-3)69 at 12 months.
H5: higher scores on measures of infants’ (a) motor development at 6 months and 12 months assessed using the Infant Neurological Examination (HINE)70 71 and (b) fine and gross motor abilities (assessed using the MSEL).72
H6: higher scores on measures of infants’ visual perceptual skills at 6 months and 12 months, assessed on the VR scores on the MSEL,24 and on symbolic cluster on the Communication and Symbolic Behavior Scales–Developmental Profile (CSBS-DP)73 and with reduced times on the gap–overlap task.
H8: better scores on parent-report measures of infant regulation—specifically, (a) lower scores for internalising and externalising behaviour, assessed on the Infant-Toddler Social and Emotional Assessment (ITSEA) at 12 months76; (b) lower scores on the dysregulation scales of the ITSEA at 12 months; (c) better sleep on the Brief Infant Sleep Questionnaire (BISQ) at 3 months and 6 months77 and (d) less cry behaviours on the Crying Pattern Questionnaire (CPQ) at 3 months and 6 months of age.78
Methods and analysis
The study is an RCT following the Consolidated Standards of Reporting Trials (CONSORT) guidelines. After enrolment, and baseline assessments, mothers of infants at risk of ASD will be randomly allocated to intervention (ENACT) or CAU. Comparison to CAU is appropriate as ENACT is a newly developed intervention and this is the first trial. The CONSORT flow chart is depicted in figure 1.
Families will be recruited via advertisements distributed through Queensland ASD family support groups, schools and clinics (eg, Autism Queensland, AEIOU Foundation for Children with Autism, Asperger Services Australia and Minds and Hearts) and Queensland Health Antenatal and Child Development Clinics. Families will be recruited during pregnancy and up to the infant reaching 7 weeks corrected age (CA) then followed over the first 12 months.
Participants must meet the following inclusion criteria: (1) the infant must have one or more biological siblings or a biological parent (mother or father) diagnosed with ASD; (2) the mother must agree to the assessment requirements; (3) the mother must have reliable internet access and (4) the mother must have sufficient English to complete assessments.
Any infant with known neurological or chromosomal disorder at the point of recruitment.
The target number of participants is 66 (ENACT, n=33; CAU, n=33), which will provide power of 80% (two-tailed, α=0.05) to detect a difference between groups of 0.75 SD on the AOSI. In a previous study with a similar sample, the observed SD was 4;30 consequently, we should be able to observe a difference of ≥3 units in this study.
Participants and intervention delivery facilitators cannot be blinded to group allocation. Assessors conducting the AOSI, gap–overlap task, MSEL and HINE assessments at 12 months CA will be blinded to group allocation, as will coders scoring the video-recorded/audio-recorded EAS observations, General Movements Assessment (GMA) and gap–overlap task.
CAU interventions for infants at risk of ASD
Participants allocated to CAU will receive usual postnatal care. As developmental and autism-related concerns generally present after 12 months of age, it is expected that any targeted interventions provided in the community by usual care providers will fall outside the timeframe of the study.
The ENACT intervention
ENACT is a very early intervention targeting infant social reciprocity through supported parent–child interactions while simultaneously supporting parental mental health and the parent–child relationship using Acceptance and Commitment Therapy (ACT). Core to ENACT is the social reciprocity intervention which teaches mothers to initiate and build sensitivity chains with their babies, with the goal that sensitivity chains become longer, increasingly complex and increasingly symbolic over time, and that the early social development of the infant is optimally supported. They should be mutually enjoyable, responsive and non-intrusive.
The three simple steps to building a sensitivity chain are for the mother to (1) stimulate an initial enjoyable interaction, (2) wait for the infant to signal their intent to continue and (3) respond to the infant’s signal, hence ‘closing the loop’ and building a link in the sensitivity chain. This will include a focus on: initially, cultivating sensitivity chains through sensorimotor activities, using positive affect and predictable surprise to support the infant’s involvement, maintaining reciprocal interactions with infants with atypical responsiveness and avoiding parental intrusiveness with atypically responsive infants. This intervention is specifically targeting the earliest documented abnormalities in social behaviour in infants at risk of ASD.79 This aspect of the ENACT intervention was developed specifically for this trial by AMG, with input from KW.
ENACT also incorporates parental mental health support grounded in ACT, including values, mindfulness, experiential acceptance and cognitive defusion (distancing from thoughts). The ACT component within ENACT contains material previously trialled as the online intervention entitled Parenting Acceptance and Commitment Therapy or PACT.51 The development of PACT was itself grounded in RCTs demonstrating the efficacy of a group ACT intervention for parents of children with neurodevelopmental disabilities.80–83 ENACT also contains a small psychoeducation component on common early parenting challenges of sleep, crying and feeding, developed by KW and grounded in the existing literature and her previous work.84–87 This focuses on understanding the biological regulation of sleep via the circadian clock and the sleep–wake homeostat, understanding the developmental pattern of infant crying, including the crying peak, and planning ahead on where to seek help for feeding challenges.
ENACT is delivered to mothers (1) via an online course (approximately 8-hour duration) using the edX platform (www.edx.org/) and (2) through telehealth (videoconferencing via Zoom) consultations with a trained clinician. The edX course includes: videos and text explaining core concepts, interactive exercises, multiple choice questions and videos of real parent-and-baby interactions. The social reciprocity very early intervention is delivered to the infant through the mother and other caregivers. Intervention delivery to mothers will commence prenatally, and mothers will receive fortnightly sessions with the clinician to support consolidation of learning. Mothers will be encouraged to work through the edX course at their own pace, with completion before their babies reach 8 weeks of age.
Mothers will be encouraged to engage in regular practice of sensitivity chains, with a goal dose of 30 min per day/5 days per week from 2 weeks of age and throughout the first year (total dose of approximately 125 hours). The social reciprocity intervention will be integrated into ordinary everyday interactions, including feeding, nappy changes and playful interactions. Consultation sessions will be conducted when the infant is 4 weeks, 8 weeks, 12 weeks, 4 months, 6 months, 8 months and 10 months of age, with capacity for additional sessions as needed. Consultations will support mothers in finding opportunities to practice within everyday life, in tailoring interactions to their babies and in adapting to their babies’ developmental stage and skills. Mothers will be encouraged to initiate a sensitivity chain during the consultation, for the clinician’s direct observation and feedback. In addition, clinical consultations will refer to ACT components, supporting maternal mental health throughout the first year. Clinical consultations will follow a specific protocol, and be recorded for fidelity (see table 1).
The primary target for recruitment and the intervention will be the mother, who will act as conduit to each infant’s caregiving system. Other caregivers (eg, fathers and grandparents) will be given access to the ENACT edX course and will be welcome to participate in clinical consultations as applicable. Mothers will also be encouraged to teach all other significant caregivers the sensitivity chain intervention via direct demonstration.
The study clinician is experienced in working with families of children with neurodevelopmental disabilities, completed general training in ACT and also completed project-specific training via the ENACT intervention manual. The clinician will receive clinical supervision from KW to support fidelity. Course completion will be checked by the clinician. Clinical consultations will follow a specific protocol and will be recorded; 20% will be checked for fidelity (content and process) against the protocol. Qualitative feedback will be collected.
Patient and public involvement
Consumer feedback was sought on the protocol, the study forms and the intervention. Consumer feedback was positive, with some changes to the wordings made following the input.
Researchers will contact interested mothers to assess eligibility and provide detailed study information (see online supplementary file S1: study information sheet and consent form). Mothers will provide written consent prior to completing baseline assessments, and computer-generated block randomisation will then be used to randomise families (1:1) to intervention or CAU via Research Electronic Data Capture (REDCap). Families allocated to intervention will receive immediate access to ENACT. Families allocated to CAU will receive routine antenatal and postnatal care.
Assessments will be conducted at baseline (prenatal), 3 months, 6 months and 12 months CA. Parents will complete questionnaire measures online; mother–infant relationship observations will be conducted via 20-minute video-recorded interactions and child development assessments will be undertaken at theUniversity of Queensland at 6 months and 12 months of age. While completing ENACT, parents will be invited to provide feedback and suggestions for course improvement.
The Parent Questionnaire collects (1) general demographic information (parent age, education, income and family composition) and (2) information relevant to the ASD context, such as parent’s health history and details of the diagnosis of the first-degree relative (parent or sibling) with ASD. Further information regarding infant delivery, perinatal history, and feeding history will be collected postnatally by a brief phone interview.
The Broad Autism Phenotype Questionnaire (36 items) assesses ASD-like features in adults through self-report or an informant measure.88 Participants rate how much each item applies to them on a 6-point Likert scale.89 Internal consistency for the total scale is excellent (α=0.95) and there is good inter-item reliability.89
The AOSI (12 months) will be the primary clinical outcome measure assessing intervention effect on infant development and severity of autism symptomatology at 12 months.62 It is an experimenter-led, semi-structured observational assessment tool, developed for research purposes to study the emergence of ASD-related behavioural markers in infancy (6–18 months).61 62 Five standardised activities are delivered between two periods of free play, with a total of 18 items to be scored. Inter-rater reliability of total marker counts (number of items marked as atypical) and total scores, respectively, is good at 6 months (0.68 and 0.74) and excellent at 12 months (0.92 and 0.93).61 Test–retest reliability for total marker counts and total scores is fair to good at 0.68 and 0.61, respectively.61 The AOSI differentiates between high-risk and low-risk infants at 12–14 months90–92.
The gap–overlap task (6 months and 12 months)63 is used to assess visual attention by measuring differences in the efficiency of orienting towards peripheral stimuli. A mix of social and non-social stimuli will be used. Two trial types will be contrasted: gap and overlap. In the gap condition, an interval of 200–250 ms separates the disappearance of the central stimulus and the appearance of the peripheral one (facilitation). In the overlap condition, the central stimulus remains visible and overlaps with the peripheral stimulus. This measures the ability to disengage from a central stimulus and to orient to a peripheral one. This difference between the gap and overlap times is called the gap effect. gap–overlap time, measured in ms, decreases from 6 months to 12 months for typically developing infants.15 93 94 Infants who are later diagnosed with ASD consistently show an increase in gap–overlap time between 6 months and 12 months of age.15 95 96 This has been called ‘sticky attention’. Test–retest reliability of the gap–overlap task’s gap effect is r=0.50 in infants of 10 months of age.63
Neurodevelopmental and motor assessments
The MSEL (6 months and 12 months) has been used in the cognitive assessment of infants and children from birth until 68 months of age.30 32 97–99 The MSEL has five scales: gross motor, VR, FM, GM, EL and RL, as well as an ELC score that is composed of the VR, FM, EL and RL subscales. The MSEL has demonstrated convergent and divergent construct validity in infants and children with ASD.100–102 Inter-rater reliability has been reported as high (r=0.91–0.99).103
The GMA (3 months) is a predictive and discriminative tool that assesses infants’ spontaneous motor activity from preterm to 20 weeks CA.104 Scoring is completed from a video recording with two full movement sequences required for pattern recognition (approximately 5 min).104 During the fidgety period from 9 weeks to 20 weeks postterm, fidgety movements can be abnormal (exaggerated in amplitude and speed), sporadic (confined to a few body parts, never >3 s between 9 and 16 weeks CA) or absent (fidgety movements not present between 9 and 16 weeks CA) (optimality scoring).104 Abnormal fidgety movements that are absent or abnormal at 12–14 weeks CA are highly predictive of cerebral palsy as well as other neurodevelopmental disabilities, including ASD.105 106 GMA will be scored by accredited blinded assessors. It will be used as a predictive tool, to better understand the sample.
The HINE (6 months and 12 months) is a standardised clinical neurodevelopmental assessment for infants from 2 months to 24 months of age.107 The HINE contains 26 items across 5 domains, summed to provide a global optimality score, and can differentiate between low-risk and high-risk late preterm and term newborns at 6 months and 12 months of age.108–110
The VABS-3 (12 months) is a standardised measure of adaptive behaviour, completed by caregivers and scored by a blinded assessor.69 Standard scores are generated for the four domains (communication, daily living skills, socialisation and motor skills) as well as a global score (Adaptive Behaviour Composite). It has good internal consistency, test–retest reliability, inter-interviewer reliability and validity for young children, including those with autism.69
The BISQ (10 items; 3 months and 6 months) assesses parent-reported infant sleep patterns (nocturnal sleep duration, night waking and method of falling asleep), parent perception of infant sleep duration and sleep-related (parent) behaviours for children from birth to 36 months. It is well validated by comparisons with actigraphy, sleep diaries and caregiver-reported sleep.77 78
The CPQ (6 items; 3 months and 6 months) is a parent-report measure assessing: (1) the amount and time of day when infant crying occurs; (2) situations in which crying occurs; (3) whether the mother finds the crying distressing and seeks advice and help and (4) the mother’s responses to crying. In comparison to 24-hour cry–fuss diaries kept by mothers, the CPQ showed moderate-to-good validity (0.51–0.68) for total duration of crying scores.78
The ITSEA (165 items; 12 months) is a parent-report questionnaire used to assess social-emotional problems/competencies in the domains of behavioural dysregulation and competence. The ITSEA has established concurrent validity, strong test-retest reliability (α=0.75–0.91) and good internal reliability for each subscale (α=0.86 for dysregulation, α=0.87 for externalising, α=0.85 for internalising and α=0.89 for competence).111 112 The ITSEA has been validated for 12 months CA and discriminates between low-risk and high-risk infants, particularly within the domain of dysregulation.76
The CSBS-DP (6 months and 12 months) evaluates the symbolic abilities and communication skills of children aged 6–24 months.73 It includes a 24-item Infant Toddler Checklist, which is used as a developmental screening tool to detect autism.113 The CSBS-DP has excellent internal consistency (α=0.86–0.92), good test–retest reliability and good construct and concurrent validity.73 114
EAS (6 months): coders, blind to intervention condition, will use the EAS to score 20-minute naturalistic observations of parent–child interactions.67 The parent–child interaction will occur in the family’s own home, with the parent instructed to interact with their child as they normally would. The observations will be recorded via the videoconferencing software Zoom. The EAS is used to measure quality of parent–child relationships across six scales: parental sensitivity, parental structuring, parental non-intrusiveness, parental non-hostility, child responsiveness and child involvement.67 The scales have high inter-rater reliability for the parent scales of sensitivity (0.95), structuring (0.87), non-intrusiveness (0.81), non-hostility (0.72) and the child scales of responsiveness (0.87) and involvement (0.87).115
The Emotional Availability-Self-Report (36 items; 3 months, 6 months and 12 months) is a parent-report questionnaire used to measure emotional availability in a dyadic relationship across five subscales: intrusiveness, hostility, mutual attunement, affect quality and capacity to involve the parent. Reliability ranges from 0.71 to 0.84 for all subscales except affect quality (α=0.49).115 All subscales (except for intrusiveness) have moderate correlations with the corresponding EAS observed subscales, thus supporting the validity of the self-report measure.115 116
Maternal mental health
The AAQ-II (7 items; baseline, 3 months, 6 months and 12 months) is a self-report questionnaire measuring psychological flexibility, the key target of ACT.66 The AAQ-II has good test–retest reliability, convergent validity and excellent internal consistency (α=0.94).66
The DASS-21 (baseline, 3 months, 6 months and 12 months) assesses symptoms of depression, anxiety and stress in adults. The DASS-21 produces three subscales, each with good internal consistency: the depression (α=0.91–0.97), anxiety (α=0.81–0.92) and stress (α=0.88–0.95) scales,117 and a total score. The DASS-21 has good convergent validity and acceptable discriminative validity.117
A comparison group of 30 healthy, low-risk infants will be recruited and assessed on the gap–overlap task and the HINE at 6 months and 12 months, and the AOSI at 12 months. This comparison data will support the interpretation of results, particularly for the novel gap–overlap task. To participate, the low-risk infant would need to have no first-degree relatives diagnosed with ASD, be born at term and have no other known developmental risk. The comparison group will be recruited through social media and word of mouth.
Data collection and management
The data will be entered onto the REDCap database in a potentially individually identifiable format. Once de-identified, the data will be stored in a re-identifiable format on a secure electronic database protected by the University of Queensland secure server, and only accessible to members of the research team.
Analysis (using STATA or SPSS 25.00) will follow standard methods for RCTs using comparisons between the two groups (eg, general linear models and Analysis of Covariance) and intention-to-treat analyses. Assumptions for parametric analyses will be assessed. Baseline scores will be included as covariates. Missing data will be handled using pro-rating and/or estimation maximisation depending on the assessment and pattern of missingness.
As this is a trial of a very early intervention with low risk, a data monitoring committee is not required. Any adverse events, particularly negative developmental outcomes, will be recorded and reported to the ethics committees and in the published results.
This study should not pose risks beyond those of everyday living. Any participants experiencing undue psychological distress will be referred to their general practitioner. For infants scoring at high developmental risk on the 12 month assessments infants’ general practitioners/paediatricians and parents will be notified. All families will be sent a paediatrician’s report detailing 12-month developmental assessment results.
Ethics and dissemination
ENACT should support mothers’ mental health and may also support infant development. Ethical approval has been obtained from the Children’s Health Queensland Hospital and Health Service Human Research Ethics Committee (HREC/19/QCHQ/50131) and the University of Queensland Human Research Ethics Committee (2019000558). Study results will be disseminated through scientific journal publications and conference presentations. If shown to be effective, edX facilitates easy dissemination at minimal cost.
This study will test the efficacy of an innovative, very early intervention for infants at risk of ASD, integrating early social reciprocity intervention with parental mental health and parent–child relationship support. Potential limitations include recruitment and retention of parents with significant caregiving responsibilities; possible overestimation of anticipated effect size; substantial burden of assessment for mothers; use of parent-report measures of infant regulation and limited ability to assess day-to-day intervention implementation by mothers in the home environment.
This work was supported by two University of Queensland Graduate School Scholarships (AM and KK), a Children’s Hospital Foundation Early Career Fellowship (AEM; award ref. no. 50223), an NHMRC Research Fellowship (RNB; 1105038) and a philanthropic donation.
Correction notice This article has been corrected since it was published. The affiliations have been updated.
Contributors All authors contributed to the conception and design of this study, contributed to drafting and critical revision of the manuscript and approved the final version of the manuscript to be submitted for publication. KW and AMG designed the ENACT intervention. KK, KW and AEM contributed to the design in terms of parental mental health and parent–child relationship assessment. AMG, KW, HH and RNB contributed to the design in terms of motor, cognitive and autistic symptomatology assessment.
Funding This work is supported by two University of Queensland Graduate School Scholarships (UQGSS) (AM and KK), a Children’s Hospital Foundation Early Career Fellowship (AEM; award ref. no. 50223), an NHMRC Research Fellowship (RNB; 1105038) and a private philanthropic donation. The private philanthropic donor does not have any role in this study
Competing interests ENACT was developed from PACT, an intervention developed by researchers at The University of Queensland, including KW and RNB. AMG and KW developed the very early intervention component of edX. ENACT has been developed using the online platform edX.
Patient and public involvement Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.